Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Injectable peperidone hydrochloride in heart failure
CTR20170434Phase 2Active
- Sponsor
- Guangzhou Zhongwei Biotechnology
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of peperidone hydrochloride in heart failure (HF), sponsored by Guangzhou Zhongwei Biotechnology. Started May 2017; status: active.
02
Drugs
peperidone hydrochloride
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on CTR20170434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170434.